Experimentally Deduced Criteria for Detection of Clinically Relevant Fusion 3' Oncogenes from FFPE Bulk RNA Sequencing Data.

Rabushko, Elizaveta; Sorokin, Maxim; Suntsova, Maria; Seryakov, Alexander P; Kuzmin, Denis V; Poddubskaya, Elena; Buzdin, Anton A

Rabushko, Elizaveta; Sorokin, Maxim; Suntsova, Maria; Seryakov, Alexander P; Kuzmin, Denis V; Poddubskaya, Elena; Buzdin, Anton A.

Affiliation

Rabushko E; Laboratory for Clinical and Genomic Bioinformatics, Institute of Personalized Oncology, I.M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia.
Sorokin M; Department of Biological and Medical Physics, Moscow Institute of Physics and Technology, 141701 Dolgoprudny, Russia.
Suntsova M; Laboratory for Clinical and Genomic Bioinformatics, Institute of Personalized Oncology, I.M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia.
Seryakov AP; Department of Biological and Medical Physics, Moscow Institute of Physics and Technology, 141701 Dolgoprudny, Russia.
Kuzmin DV; OmicsWay Corp., 340 S Lemon Ave, 6040, Walnut, CA 91789, USA.
Poddubskaya E; Laboratory for Clinical and Genomic Bioinformatics, Institute of Personalized Oncology, I.M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia.
Buzdin AA; Department of Biological and Medical Physics, Moscow Institute of Physics and Technology, 141701 Dolgoprudny, Russia.

Biomedicines ; 10(8)2022 Aug 02.

Article de En | MEDLINE | ID: mdl-36009413

Mots clés

FFPE; RNA sequencing; RNAseq; clinical oncology; fusion oncogene; receptor tyrosine kinase; tumor molecular diagnostics

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Diagnostic_studies / Prognostic_studies Langue: En Journal: Biomedicines Année: 2022 Type de document: Article Pays d'affiliation: Russie Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google